| Variables |
Area |
Standard error |
p value |
95% Confidence interval |
| Lower limit |
Upper limit |
| Age |
0.507 |
0.602 |
0.93 |
0.374 |
0.575 |
| Sex |
0.615 |
0.079 |
0.149 |
0.447 |
0.669 |
| BMI |
0.412 |
0.082 |
0.823 |
0.324 |
0.548 |
| Diabetes mellitus |
0.486 |
0.08 |
0.865 |
0.332 |
0.561 |
| ALT |
0.62 |
0.077 |
0.129 |
0.556 |
0.757 |
| Genotypes |
0.428 |
0.08 |
0.371 |
0.306 |
0.525 |
| Log W0 |
0.198 |
0.045 |
0 |
0.206 |
0.387 |
| Log W1 |
0.199 |
0.059 |
0 |
0.161 |
0.339 |
| Log W4 |
0.334 |
0.085 |
0.037 |
0.237 |
0.473 |
| ε |
0.728 |
0.064 |
0.004 |
0.612 |
0.794 |
| δ |
0.682 |
0.7 |
0.022 |
0.582 |
0.772 |
| π |
0.774 |
0.06 |
0.001 |
0.652 |
0.828 |
| BMI: Body Mass Index; ALT: Alanine Aminotransferase; Log W0: Logarithm of Baseline: HCV RNA level; Log W1: Logarithm of HCV RNA level at week 1; Log W4: Logarithm of HCV RNA level at week 4; ε: Logarithm of HCV RNA level at week 1 divided by baseline level; δ: Logarithm of the decline in HCV RNA level (viral decay slope); π: The ratio of 1: α (α=trapezoidal area under the line between week 0 and week 1). |
|